Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-11975045-B2 United States of America 07 May 2024
Methods of associating genetic variants with a clinical outcome in patients suffering… Grant US-11769597-B2 United States of America 26 Sep 2023
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-11730794-B2 United States of America 22 Aug 2023
Use of a VEGF antagonist to treat angiogenic eye disorders Grant US-11707506-B2 United States of America 25 Jul 2023